RELATED STUDY
Key Findings:
Type of Study:
Study Result: Inconclusive
Research Location(s):
Year of Pub:
Cannabinoids Studied:
Chemotype:
Terpenes Studied:
Receptors Studied:
Ligands Studied:
DOSING DETAILS 
Study Dosing Objective: Effective Dose
Established Protocol: Effective dose
Route of Administration:
Dosing Regimen: CBD 5 mg/kg or terpenoid-rich essential oils 10, 25, or 50 mg/kg
Clinical Relevance: Terpenoid-rich essential oils exert anti-inflammatory and antinociceptive activities in vitro and in vivo, but none of the essential oils were as effective as purified CBD. CBD might be useful in chronic inflammation.
Citation:
